Real-World Clinical Evaluation of the Shockwave Intravascular Lithotripsy (IVL) Catheter System for Treating Severe Calcified Lesions in Femoropopliteal Arteries

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

There is a lack of prospective observational studies of shockwave balloons in the treatment of moderate-to-severe calcification of the femoral popliteal artery at the international level. Therefore, in this study, we wish to set up a real-world study of shockwave balloon in the treatment of moderate-to-severe calcification to investigate the real-world efficacy of shockwave balloon in the treatment of moderate-to-severe calcified lesions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \-

• 1\) Age ≥ 18 years (2) Rutherford Classification 2-5 3) Stenosis (\>70% stenosis confirmed by digital subtraction angiography (DSA) imaging) or occlusion of the femoropopliteal artery, with one healthy patent outflow tract distal to the knee in continuity with a patent outflow tract below the ankle.

• (4) Patients who understand the purpose of the study, participate in the experiment voluntarily, sign the informed consent form and are willing to be followed up.

• 5\) The guidewire needs to pass through the lesion; 6) Life expectancy \>24 months 7) Moderately severe calcified lesions confirmed by imaging data: 8) For patients who receive intervention in both lower extremities may be enrolled in order of time of intracavitary treatment 9) For combined aortoiliac artery lesions that have undergone endoluminal revascularization to achieve flow recanalization without more than 50% residual stenosis.

Locations
Other Locations
China
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Zibo Feng, MD
fengzibo@hust.edu.cn
86-13545160302
Backup
Ye Du, DM
duye@hust.edu.cn
86-15827105515
Time Frame
Start Date: 2024-12-01
Estimated Completion Date: 2028-11
Participants
Target number of participants: 130
Sponsors
Leads: Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Collaborators: RenJi Hospital, Xuanwu Hospital, Beijing, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, The General Hospital of Southern Theater Command, Huashan Hospital, Shanghai Zhongshan Hospital, Chengdu University of Traditional Chinese Medicine

This content was sourced from clinicaltrials.gov